Schroeder Jennifer R, Gupman Anne E, Epstein David H, Umbricht Annie, Preston Kenzie L
Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, USA.
Exp Clin Psychopharmacol. 2003 Aug;11(3):195-201. doi: 10.1037/1064-1297.11.3.195.
Data from 2 contingency management trials, targeting opiate or cocaine use, were used to investigate whether noncontingent vouchers inadvertently reinforce drug use. The control group in each trial received noncontingent vouchers matched in value and frequency to those received by experimental groups, but independent of urinalysis. Vouchers were offered thrice weekly for 8 weeks (opiates) or 12 weeks (cocaine). Both dose-response and temporal associations of noncontingent voucher receipt with drug-positive urines were assessed. Drug use was unrelated to frequency of noncontingent voucher delivery and noncontingent voucher receipt when being drug positive was unassociated with risk of subsequent drug use, with one exception: cocaine use in the cocaine study (relative risk = 1.05, 95% confidence interval: 1.01-1.09). Overall, results do not indicate a causal relationship between noncontingent voucher receipt and increased drug use.
来自两项针对阿片类药物或可卡因使用的应急管理试验的数据,被用于调查非应急代金券是否会无意中强化药物使用。每项试验中的对照组接受了在价值和频率上与实验组所接受的代金券相匹配,但与尿液分析无关的非应急代金券。代金券每周提供三次,持续8周(阿片类药物)或12周(可卡因)。评估了非应急代金券领取与药物阳性尿液之间的剂量反应和时间关联。当药物阳性与后续药物使用风险无关时,药物使用与非应急代金券发放频率和非应急代金券领取无关,但有一个例外:可卡因研究中的可卡因使用(相对风险 = 1.05,95%置信区间:1.01 - 1.09)。总体而言,结果并未表明非应急代金券领取与药物使用增加之间存在因果关系。